Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05800899 · ClinicalTrials.gov registry record · NA

Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs

A NA study of Alcohol Use Disorder, sponsored by University of Texas, El Paso.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT05800899: Recruiting NA study of Alcohol Use Disorder, sponsored by University of Texas, El Paso.

NCT05800899 is a NA study of Alcohol Use Disorder that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 600 participants, above the 325-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (85% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05800899, a NA study of Alcohol Use Disorder, is actively recruiting participants, sponsored by University of Texas, El Paso.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drinking or were drinking at the time of their injury. The culturally informed brief motivational intervention (CI-BMI) increases autonomous motivation to engage in protective drinking behavior and reduce alcohol problems while addressing barriers to help seeking and facilitating treatment utilization. This project will address the alcohol related health disparities and treatment inequities among Latinx who are more likely to experience alcohol problems yet less likely to receive treatment in order to reduce the negative public health impact of alcohol.

Primary Outcome

The 20-item Protective Behavioral Strategies Scale (PBSS) will be used to quantify the engagement in harm reduction behaviors which will be assessed at baseline, three, six and twelve month follow up. The PBSS consists of three subscales that reflect different types of strategies: stopping/limiting drinking (7 items), manner of drinking (5 items), and serious harm reduction (3 items). Participants are instructed to rate the degree to which they engage in PBS on a 6-point response scale ranging f

Conditions Studied

Interventions

  • BEHAVIORAL Brief Motivational Interviewing
  • BEHAVIORAL Culturally adaptation brief motivational interviewing

Study Locations (1)

Texas

  • University Medical Center of El Paso - El Paso

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2023-06-30
Est. Completion 2027-06-30
Phase NA
University of Texas, El Paso

17 total trials

What NCT05800899 shows while recruiting

NCT05800899 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 325-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (85% higher).

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Brief Motivational Interviewing is the first listed.

NCT05800899 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05800899 about?

NCT05800899 is a clinical study titled "Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs". This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drink...

What is the current status of trial NCT05800899?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-06-30. Estimated completion is 2027-06-30.

What conditions does trial NCT05800899 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT05800899?

The interventions under investigation include: Brief Motivational Interviewing (BEHAVIORAL), Culturally adaptation brief motivational interviewing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05800899?

This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05800899 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05800899's enrollment target sits among peer trials

600 12th of 184 higher than 173 of 184 other Alcohol Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05800899, the US trial registry maintained by the National Library of Medicine. NCT05800899 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.